Production (Stage)
Genocea Biosciences, Inc.
GNCAQ
$0.00
$0.000.00%
OTC PK
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.14M | 37.15M | 48.91M | 60.40M | 66.04M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.27M | 4.67M | 1.71M | 2.51M | 2.79M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 24.41M | 41.82M | 50.61M | 62.91M | 68.82M |
|
|
|||||
| Total Current Assets | 24.41M | 41.82M | 50.61M | 62.91M | 68.82M |
| Net Property, Plant & Equipment | 13.50M | 13.26M | 13.42M | 13.59M | 13.68M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 884.00K | 884.00K | 884.00K | 885.00K | 1.43M |
| Total Assets | 38.79M | 55.97M | 64.92M | 77.38M | 83.94M |
|
|
|||||
| Total Accounts Payable | 594.00K | 500.00K | 978.00K | 1.36M | 1.03M |
| Total Accrued Expenses | 7.55M | 8.25M | 5.79M | 5.52M | 3.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.11M | 6.99M | 6.87M | 5.50M | 4.16M |
| Total Finance Division Other Current Liabilities | 2.77M | 2.95M | 1.07M | 2.45M | 2.51M |
| Total Other Current Liabilities | 2.77M | 2.95M | 1.07M | 2.45M | 2.51M |
| Total Current Liabilities | 18.03M | 18.68M | 14.70M | 14.83M | 11.42M |
|
|
|||||
| Total Current Liabilities | 18.03M | 18.68M | 14.70M | 14.83M | 11.42M |
| Long-Term Debt | 2.95M | 4.15M | 5.33M | 6.49M | 7.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.43M | 6.05M | 6.66M | 7.26M | 7.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 11.00K | 398.00K | 44.75M | 55.26M |
| Total Liabilities | 26.40M | 28.89M | 27.09M | 73.33M | 82.18M |
|
|
|||||
| Common Stock & APIC | 436.23M | 434.94M | 432.41M | 395.02M | 388.41M |
| Retained Earnings | -423.84M | -407.86M | -394.58M | -390.96M | -386.65M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 12.39M | 27.08M | 37.83M | 4.06M | 1.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.39M | 27.08M | 37.83M | 4.06M | 1.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.39M | 27.08M | 37.83M | 4.06M | 1.76M |
|
|
|||||